HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Nyberg Selected Research

P Nyberg Research Topics

Disease

2Neoplasms (Cancer)
05/2021 - 12/2002
2Foot Ulcer
12/2015 - 10/2014
2Ulcer
12/2015 - 03/2009
2Hypertension (High Blood Pressure)
01/2008 - 03/2003
2Intervertebral Disc Displacement (Herniated Disc)
08/2005 - 04/2005
1Diabetic Foot
12/2015
1Myoma
10/2010
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2009
1Type 2 Diabetes Mellitus (MODY)
03/2009
1Infections
03/2009
1Congenital Abnormalities (Deformity)
03/2009
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
03/2009
1Body Weight (Weight, Body)
01/2008
1Glucose Intolerance
01/2008
1Abdominal Obesity
01/2008
1Cardiovascular Diseases (Cardiovascular Disease)
10/2007
1Chronic Obstructive Pulmonary Disease (COPD)
05/2006
1Asthma (Bronchial Asthma)
05/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2004
1Venous Thrombosis (Deep-Vein Thrombosis)
09/2004
1Diabetes Mellitus
09/2004
1Myalgia
11/2000
1Muscle Weakness
04/2000
1Polymyositis
04/2000
1Dermatomyositis (Dermatopolymyositis)
04/2000
1Fatigue
04/2000
1Wounds and Injuries (Trauma)
03/2000

Drug/Important Bio-Agent (IBA)

3Triglycerides (Triacylglycerol)IBA
01/2008 - 03/2003
2Matrix Metalloproteinases (MMPs)IBA
05/2021 - 12/2002
2CholesterolIBA
01/2008 - 09/2004
2HDL CholesterolIBA
01/2008 - 09/2004
1OligonucleotidesIBA
10/2010
1Insulin (Novolin)FDA Link
03/2009
1Adenosine Triphosphate (ATP)IBA
01/2008
1LipidsIBA
10/2007
1AndrogensIBA
10/2007
1SteroidsIBA
05/2006
1LDL CholesterolIBA
09/2004
1Blood Glucose (Blood Sugar)IBA
03/2003
1GelatinasesIBA
12/2002
1C-Reactive ProteinIBA
11/2000
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2000
1Histocompatibility Antigens Class IIBA
04/2000
1Interleukin-1alpha (Interleukin 1 alpha)IBA
04/2000
1nasIBA
03/2000

Therapy/Procedure

3Surgical Amputation (Amputations)
12/2015 - 03/2009
2Diskectomy (Discectomy)
08/2005 - 04/2005
1Vascular Surgical Procedures
12/2015
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
10/2007